Supplementary Table 1 from SCUBE3 Exerts a Tumor-Promoting Effect in Tongue Squamous Cell Carcinoma by Promoting CEBPA Binding to the CCL2 Promoter

Minhui Zhu,Yi Ma,Wei Wang,Meng Li,Shicai Chen,Fei Liu,Xiaoqiong Shi,Hongsen Bi,Chen Zhang,Fangfei Nie,Hongliang Zheng,Caiyun Zhang

DOI: https://doi.org/10.1158/1541-7786.25736168.v1

2024-01-01

Abstract:Table S1. The shRNA target sequences and scramble sequence (NC).

What problem does this paper attempt to address?

Supplementary Table 2 from SCUBE3 Exerts a Tumor-Promoting Effect in Tongue Squamous Cell Carcinoma by Promoting CEBPA Binding to the CCL2 Promoter

Minhui Zhu,Yi Ma,Wei Wang,Meng Li,Shicai Chen,Fei Liu,Xiaoqiong Shi,Hongsen Bi,Chen Zhang,Fangfei Nie,Hongliang Zheng,Caiyun Zhang

DOI: https://doi.org/10.1158/1541-7786.25736165

2024-01-01

Abstract:Table S2. Primers used in qPCR.
Supplementary Figure 1 from SCUBE3 Exerts a Tumor-Promoting Effect in Tongue Squamous Cell Carcinoma by Promoting CEBPA Binding to the CCL2 Promoter

Minhui Zhu,Yi Ma,Wei Wang,Meng Li,Shicai Chen,Fei Liu,Xiaoqiong Shi,Hongsen Bi,Chen Zhang,Fangfei Nie,Hongliang Zheng,Caiyun Zhang

DOI: https://doi.org/10.1158/1541-7786.25736171.v1

2024-01-01

Abstract:Supplementary Figure 1. Validation of three SCUBE3 shRNA clones was performed by qPCR analysis. Results were presented as mean ± SD. **P<0.01.
Supplementary Table 3 from SCUBE3 Exerts a Tumor-Promoting Effect in Tongue Squamous Cell Carcinoma by Promoting CEBPA Binding to the CCL2 Promoter

Minhui Zhu,Yi Ma,Wei Wang,Meng Li,Shicai Chen,Fei Liu,Xiaoqiong Shi,Hongsen Bi,Chen Zhang,Fangfei Nie,Hongliang Zheng,Caiyun Zhang

DOI: https://doi.org/10.1158/1541-7786.25736162

2024-01-01

Abstract:Table S3. Antibodies applied in Western blot and co-IP assay of this research.
SCUBE3 exerts a tumor-promoting effect in tongue squamous cell carcinoma by promoting CEBPA binding to the CCL2 promoter

Minhui Zhu,Yi Ma,Wei Wang,Meng Li,Shicai Chen,Fei Liu,Xiaoqiong Shi,Hongsen Bi,Chen Zhang,Fangfei Nie,Hongliang Zheng,Caiyun Zhang

DOI: https://doi.org/10.1158/1541-7786.mcr-23-0038

2024-02-14

Molecular Cancer Research

Abstract:Tongue squamous cell carcinoma (TSCC) is the main pathological subtype of oral cancer, and the current therapeutic effect is far from satisfactory. The signal peptide-CUB-EGF domain-containing protein 3 (SCUBE3) has been shown to be a tumor-promoting factor in several malignancies. However, little is known about the role of SCUBE3 in TSCC. In this study, we identified that SCUBE3 was highly expressed in TSCC. Clinically, high expression of SCUBE3 was positively associated with tumor stage and T stage of TSCC. Functionally, SCUBE3 silence remarkably restrained cell proliferation, migration and invasion, induced apoptosis as well as cell cycle arrest in G2 phase, and weakened the tumorigenicity of TSCC cells in vivo. Mechanistically, SCUBE3 promoted the direct binding of CCAAT enhancer binding protein alpha (CEBPA) to C-C motif chemokine ligand 2 (CCL2) promoter in TSCC cells. Interestingly, CCL2 overexpression partially reversed the inhibitory effect of SCUBE3 deficiency on TSCC cell viability and migration. Moreover, signal transducer and activator of transcription 3 (STAT3) signaling contributed to CCL2-mediated phenotypes in TSCC cells. Implications: our data revealed a tumor-promoting role for SCUBE3 in TSCC via the CEBPA/ CCL2/STAT3 axis, which provided new insight into novel potential therapeutic target for TSCC.

oncology,cell biology
Supplementary Table S1 from Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer

Yuning Liu,Qingzhe Wu,Bin Jiang,Tingting Hou,Chuanqiang Wu,Ming Wu,Hai Song

DOI: https://doi.org/10.1158/1541-7786.26144994

2024-01-01

Abstract:Supplementary Table S1. Sequences for sgRNA, shRNA or siRNA.
Supplementary Table 1 from CD47-SIRPα Blockade Sensitizes Head and Neck Squamous Cell Carcinoma to Cetuximab by Enhancing Macrophage Adhesion to Cancer Cells

Bolei Li,Yu Hao,Hongzhi He,Yu Fan,Biao Ren,Xian Peng,Xuedong Zhou,Lei Cheng

DOI: https://doi.org/10.1158/0008-5472.27236477

2024-01-01

Abstract:sgRNA sequences of the CRISPR pooled library
[Effects of Epidermal Growth Factor Receptor Gene Silencing Mediated by Short Hairpin RNA on Proliferation and Apoptosis of Human Tongue Carcinoma Cells].

Hong-jie Huang,Fei-yun Ping,Ji-an Hu,Shi-fang Zhao

DOI: https://doi.org/10.3760/cma.j.issn.1002-0098.2009.06.013

2009-01-01

Abstract:OBJECTIVETo investigate the effects of epidermal growth factor receptor (EGFR) gene silencing mediated by short hairpin RNA (shRNA) on proliferation and apoptosis of human tongue carcinoma cells.METHODSshRNA eukaryotic expression vector targeting the specific sequence of human EGFR gene was constructed and termed shEGFR. The control vector targeting the unrelated sequence was also constructed and termed shNC. The vectors were transiently transfected into Tca8113 cells of human tongue squamous cell carcinoma by Lipofectamine 2000, respectively. The mRNA and protein levels of EGFR in Tca8113 cells were detected by reverse transcriptase polymerase chain reaction (RT-PCR) and Western blotting. The cell proliferation of Tca8113 cells was evaluated by methyl thiazolyl tetrazolium (MTT) assay. The apoptosis of Tca8113 cells was assessed by flow cytometry.RESULTSEGFR expression in Tca8113 cells transfected with shEGFR were obviously decreased at mRNA level (81.6%) and protein level (72.0%) (P < 0.05) 48 h after transfection of shEGFR compared with untransfected Tca8113 cells. The proliferation activity of Tca8113 cells transfected with shEGFR was significantly lower than that of Tca8113 cells transfected with shNC and untransfected Tca8113 cells (P < 0.05). The early apoptotic rate of Tca8113 cells transfected with shEGFR was significantly higher than that of Tca8113 cells transfected with shNC and untransfected Tca8113 cells [(39.4 +/- 7.7)%, (4.3 +/- 1.2)%, (2.5 +/- 0.9)%, P < 0.05] 48 h after transfection of shEGFR.CONCLUSIONSEGFR gene silencing mediated by shRNA may inhibit cell proliferation and induce apoptosis in human tongue carcinoma cells.
CBX3 Promotes Tumor Proliferation by Regulating G1/S Phase Via P21 Downregulation and Associates with Poor Prognosis in Tongue Squamous Cell Carcinoma.

HuaYong Zhang,WeiChao Chen,XiaoYan Fu,Xuan Su,AnKui Yang

DOI: https://doi.org/10.1016/j.gene.2018.02.043

IF: 3.913

2018-01-01

Gene

Abstract:Chromobox protein homolog 3 (CBX3), a core component of the heterochromatin proteins 1, is recently proved to be involved in human cancerogenesis and associated with the prognosis of patient. However, the role of CBX3 in Tongue squamous cell carcinoma (TSCC) remains unclear. In the present study we found that CBX3 was upregulated in TSCC tissues when compared to adjacent non-tumor tissues, and multivariable analysis showed that high CBX3 expression was associated with clinical stage and cervical node metastasis, which was an independent prognostic indicator of TSCC. Furthermore, Kaplan-Meier survival analysis and log-rank test showed that TSCC patients with high CBX3 expression had a poorer rate of OS compared to patients with low CBX3 expression. Moreover, knocking down CBX3 inhibited TSCC cells proliferation both in vitro and in vivo, while overexpressing CBX3 promoted TSCC cells proliferation. In addition, CBX3 depletion resulted in cell cycle delay at the G1/S phase via the p21 pathway. In summary, we identifies CBX3 as a potential novel oncogene in TSCC, which may act as a biomarker and target in the diagnosis and treatment of this killer disease.
MicroRNA-532-3p Suppresses Malignant Behaviors of Tongue Squamous Cell Carcinoma Via Regulating CCR7

Cuijuan Feng,Hyon Il So,Shoucheng Yin,Xingzhou Su,Qiang Xu,Simin Wang,Weiyi Duan,Enjiao Zhang,Changfu Sun,Zhongfei Xu

DOI: https://doi.org/10.3389/fphar.2019.00940

IF: 5.6

2019-01-01

Frontiers in Pharmacology

Abstract:To provide better therapeutic avenues for treating tongue squamous cell carcinoma (TSCC), a series of experiments about the effects of microRNA (miR)-532-3p on TSCC malignant behaviors were carried out. The result showed that miR-532-3p was down-regulated and C-C chemokine receptor 7 (CCR7) was up-regulated in the tumor tissues compared with those in the paired paratumor tissues. Further, expression of miR-532-3p was detected in four TSCC cell lines, TSCCA, TCA8113, CAL-27, and SCC-25. The miR-532-3p mimics and inhibitor were transfected into the CAL-27 and TCA8113 cell lines which were the relatively lowest and highest miR-532-3p expressions, respectively. It was found that the overexpression of miR-532-3p suppressed TSCC cell proliferation, migration, invasion, and promoted apoptosis in vitro, whilst the knockdown of miR-532-3p reversed these behaviors. The bioinformatics predicted that CCR7 was a downstream gene of miR-532-3p, which was confirmed via luciferase assay. Following, the decline of CCR7 in the miR-532-3p mimics group and the rise of CCR7 in the miR-532-3p inhibitor group were also verified. In addition, enhanced cell proliferation, migration and invasion induced by CCR7 were partly restrained by miR-532-3p in TSCC cell. Meanwhile, miR-532-3p attenuated tumourigenesis in vivo due to the reduction of tumor volume and Ki-67 positive rate and the increase of apoptotic cells. Taken together, these findings reveal a pivotal role for the miR-532-3p/CCR7 axis in regulating TSCC, and this novel axis could be suitable for therapeutic intervention in TSCC disease.
Targeted Silencing of Cxcr4 Inhibits Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma

Yuansheng Duan,Shu Zhang,Longlong Wang,Xuan Zhou,Qinghua He,Su Liu,Kai Yue,Xudong Wang

DOI: https://doi.org/10.3892/ol.2016.4838

2016-01-01

Oncology Letters

Abstract:Aberrant overexpression of C-X-C chemokine receptor type 4 (CXCR4) is a critical event during tumor metastasis. It has been previously reported that the expression of CXCR4 is linked with epithelial-mesenchymal transition (EMT) in oral squamous cell carcinoma (OSCC) tissues derived from patients. The present study addresses the role of CXCR4 in EMT in tongue squamous cell carcinoma (TSCCA) cells in vitro and in xenograft models. Small interfering (si) RNA sequences targeting the CXCR4 gene were transfected into TSCCA cells. Cell migration, invasion, apoptosis and EMT markers were determined in TSCCA cells using wound healing and Transwell assays, Annexin V/propdidum iodide double staining and western blot analysis, respectively. In vivo, tumor growth was assessed by subcutaneous inoculation of cells into BALB/c nude mice. Phenotypic EMT markers and regulatory factors were detected in the tumor tissues derived from the mice. In vitro, silencing of CXCR4 expression suppressed cell migration and invasion, and induced apoptosis. The protein expression of the EMT-associated markers N-cadherin and matrix metalloproteinases 2/9 were attenuated, while E-cadherin was increased. In vivo, CXCR4 siRNA inhibited tumor growth, and EMT-associated proteins had similar expression patterns to the experimental results observed in vitro. In conclusion, the present study demonstrated that CXCR4 silencing suppressed EMT in OSCC, thus affecting tumor metastasis.
Supplementary Table 1 from CCL26 Participates in the PRL-3–Induced Promotion of Colorectal Cancer Invasion by Stimulating Tumor-Associated Macrophage Infiltration

Qing Lan,Lai Wei,Yujie Zeng,Lu Liu,Shoufeng Li,Shaowen Jin,Yang Zhang,Xingxi Luo,Hui Xu,Xiaoyan Lin,Zhonghua Chu

DOI: https://doi.org/10.1158/1535-7163.22504720.v1

2023-01-01

Abstract:The catalog number of antibodies, blocking reagent and dilutions.
Supplementary Tables S1-S8 from Targeting the c-Met/FZD8 Signaling Axis Eliminates Patient-Derived Cancer Stem–like Cells in Head and Neck Squamous Carcinomas

Shuyang Sun,Suling Liu,Sheng Zhong Duan,Lei Zhang,Henghua Zhou,Yongjie Hu,Xianghui Zhou,Chaoji Shi,Rong Zhou,Zhiyuan Zhang

DOI: https://doi.org/10.1158/0008-5472.22403972

2023-01-01

Abstract:Supplementary Tables S1-S8. Clinical and pathologic characteristics of SCCHN patients ; Tumorigenicity of sorted primary SCCHN cells using c-Met and CD44 markers ; The effects of c-Met knockdown on the tumor-initiating capacity of HN-CSCs ; The secondary tumor-initiating ability of cells obtained from the xenografts treated with the indicated agents ; The tumor-initiating capacity of HN-CSCs with Axin or DKK-1 overexpression ; Tumor-initiating ability of HN-CSCs with different treatments ; The target sequence of shRNAs ; Primer sequences for qPCR analyses .
MTA3-SOX2 Module Regulates Cancer Stemness and Contributes to Clinical Outcomes of Tongue Carcinoma

Zhimeng Yao,Liang Du,Min Xu,Kai Li,Haipeng Guo,Guodong Ye,Dianzheng Zhang,Robert P. Coppes,Hao Zhang

DOI: https://doi.org/10.3389/fonc.2019.00816

IF: 4.7

2019-01-01

Frontiers in Oncology

Abstract:Cancer cell plasticity plays critical roles in both tumorigenesis and tumor progression. Metastasis-associated protein 3 (MTA3), a component of the nucleosome remodeling and histone deacetylase (NuRD) complex and multi-effect coregulator, can serve as a tumor suppressor in many cancer types. However, the role of MTA3 in tongue squamous cell cancer (TSCC) remains unclear although it is the most prevalent head and neck cancer and often with poor prognosis. By analyzing both published datasets and clinical specimens, we found that the level of MTA3 was lower in TSCC compared to normal tongue tissues. Data from gene set enrichment analysis (GSEA) also indicated that MTA3 was inversely correlated with cancer stemness. In addition, the levels of MTA3 in both samples from TSCC patients and TSCC cell lines were negatively correlated with SOX2, a key regulator of the plasticity of cancer stem cells (CSCs). We also found that SOX2 played an indispensable role in MTA3-mediated CSC repression. Using the mouse model mimicking human TSCC we demonstrated that the levels of MTA3 and SOX2 decreased and increased, respectively, during the process of tumorigenesis and progression. Finally, we showed that the patients in the MTA3low/SOX2high group had the worst prognosis suggesting that MTA3low/SOX2high can serve as an independent prognostic factor for TSCC patients. Altogether, our data suggest that MTA3 is capable of repressing TSCC CSC properties and tumor growth through downregulating SOX2 and MTA3low/SOX2high might be a potential prognostic factor for TSCC patients.
Additional File 1 of Association of CASC18/miR-20a-3p/TGFB2 Cerna Axis with Occult Lymph Node Metastasis in Tongue Squamous Cell Carcinoma

Bo Zhang,Yifeng Zhou,Ying Li,Hailin Zhang,Huangxing Mao,Mingjing Peng,Anji Xu,Zan Li,Hui Wang,Hao-lei Tan,Huayi Ren,Xiao Zhou,Ying Long

DOI: https://doi.org/10.6084/m9.figshare.15128516

2021-01-01

Abstract:Additional file 1: Lists of differentially expressed genes in this work.
Supplemental Tables from Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC

Yun Liu,Xinran Zhang,Baicai Yang,Hao Zhuang,Hua Guo,Wen Wei,Yuan Li,Ruibing Chen,Yongmei Li,Ning Zhang

DOI: https://doi.org/10.1158/0008-5472.22418658

2023-01-01

Abstract:This file contains all Supplemental tables that including clinicopathological information of HCC tissue samples and sequences of DNA primer, siRNAs, and shRNAs.
Supplementary Table I and II from PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer

Nisha Nagarsheth,Dongjun Peng,Ilona Kryczek,Ke Wu,Wei Li,Ende Zhao,Lili Zhao,Shuang Wei,Timothy Frankel,Linda Vatan,Wojciech Szeliga,Yali Dou,Scott Owens,Victor Marquez,Kaixiong Tao,Emina Huang,Guobin Wang,Weiping Zou

DOI: https://doi.org/10.1158/0008-5472.22409408.v1

2023-01-01

Abstract:This is Supplementary Tables I and II Table 1: RT-PCR primers and ChIP primers Table 2: shRNA Sequences
Supplementary Table 1 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression

Yongheng Chen,Ying,Wenlong Ma,Hongchao Ma,Liang Shi,Xuefeng Gao,Min Jia,Meiqi Li,Xiaoman Song,Weixiao Kong,Wei Chen,Xiangyi Zheng,Tobias Achu Muluh,Xiaobin Wang,Maolin Wang,Xing-sheng Shu

DOI: https://doi.org/10.1158/0008-5472.25603759

2024-01-01

Abstract:Target sequences of shRNAs and sgRNAs used in this study.
Supplementary Table S2 from CD36+ Proinflammatory Macrophages Interact with ZCCHC12+ Tumor Cells in Papillary Thyroid Cancer Promoting Tumor Progression and Recurrence

Xin Zhang,Limei Guo,Wenyu Tian,Ying Yang,Yue Yin,Yaruo Qiu,Weixuan Wang,Yang Li,Guangze Zhang,Xuyang Zhao,Guangxi Wang,Zhiqiang Lin,Meng Yang,Wei Zhao,Dan Lu

DOI: https://doi.org/10.1158/2326-6066.27601852

2024-01-01

Abstract:Supplementary Table S2 Clinicopathological characteristics of patients for scRNA-seq data.
Sox2 Promotes Tumor Aggressiveness and Epithelial‑mesenchymal Transition in Tongue Squamous Cell Carcinoma.

Xingguang Liu,Bin Qiao,Tengda Zhao,Fengchun Hu,Alfred King-Yin Lam,Qian Tao

DOI: https://doi.org/10.3892/ijmm.2018.3742

IF: 5.314

2018-01-01

International Journal of Molecular Medicine

Abstract:Tongue squamous cell carcinoma (TSCC) is highly malignant and poorly differentiated, resulting in a high frequency of local recurrence and distant metastases. Sox2 (Sry-box2), an important factor in embryonic development and cell differentiation, has been shown to associate with malignant phenotypes and epithelial-mesenchymal transition (EMT) progression in numerous types of human tumors. However, the clinical relevance and molecular mechanisms of Sox2 in TSCC remain unclear. In the present study, the expression levels of Sox2 were assessed in 61 pairs of TSCC samples and corresponding adjacent non-cancerous tissues using immunohistochemical methods. Associations between Sox2 expression and clinicopathological features were evaluated. Furthermore, Sox2 was overexpressed and inhibited using full-length Sox2 cDNA and short hairpin RNA (shRNA) transfection in UM2 and Cal27 cell lines, respectively. The malignant phenotypes were assessed by plate clone formation assays, wound-healing assays and Transwell assays. EMT markers (E-cadherin, vimentin, Twist, Slug and Snail) and beta-catenin were detected by reverse transcription-polymerase chain reaction and western blot analysis following the alterations of Sox2 expression. The results indicated that Sox2 expression was markedly upregulated in TSCC samples and was significantly associated with tumor growth (pT stage), cell differentiation, lymphatic metastasis (pN stage) and clinical stage (pTNM stage). Cal27-shRNA-Sox2 cells not only exhibited a decreased capacity for cell proliferation, but also suppressed cell migration and invasion, and an attenuated colony formation capacity. By contrast, UM2-Sox2 cells exhibited accelerated cell malignant phenotypes and EMT progression. Moreover, when the expression of Sox2 was decreased by shRNA transduction, beta-catenin expression was attenuated. An opposing phenomenon was observed in UM2-Sox2 cells. In conclusion, this study suggests that Sox2 expression serves a role in TSCC malignant phenotypes and EMT progression, and that beta-catenin may act as a modulated factor in this progression.
Supplementary Table 1 from A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis

Ling-Min Kong,Cheng-Gong Liao,Yang Zhang,Jing Xu,Yu Li,Wan Huang,Yi Zhang,Huijie Bian,Zhi-Nan Chen

DOI: https://doi.org/10.1158/0008-5472.22402862

2023-01-01

Abstract:PDF file - 75K, Oligonucleotide sequence of PCR primers and siRNA fragments.

Supplementary Table 1 from SCUBE3 Exerts a Tumor-Promoting Effect in Tongue Squamous Cell Carcinoma by Promoting CEBPA Binding to the CCL2 Promoter

Supplementary Table 2 from SCUBE3 Exerts a Tumor-Promoting Effect in Tongue Squamous Cell Carcinoma by Promoting CEBPA Binding to the CCL2 Promoter

Supplementary Figure 1 from SCUBE3 Exerts a Tumor-Promoting Effect in Tongue Squamous Cell Carcinoma by Promoting CEBPA Binding to the CCL2 Promoter

Supplementary Table 3 from SCUBE3 Exerts a Tumor-Promoting Effect in Tongue Squamous Cell Carcinoma by Promoting CEBPA Binding to the CCL2 Promoter

SCUBE3 exerts a tumor-promoting effect in tongue squamous cell carcinoma by promoting CEBPA binding to the CCL2 promoter

Supplementary Table S1 from Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer

Supplementary Table 1 from CD47-SIRPα Blockade Sensitizes Head and Neck Squamous Cell Carcinoma to Cetuximab by Enhancing Macrophage Adhesion to Cancer Cells

[Effects of Epidermal Growth Factor Receptor Gene Silencing Mediated by Short Hairpin RNA on Proliferation and Apoptosis of Human Tongue Carcinoma Cells].

CBX3 Promotes Tumor Proliferation by Regulating G1/S Phase Via P21 Downregulation and Associates with Poor Prognosis in Tongue Squamous Cell Carcinoma.

MicroRNA-532-3p Suppresses Malignant Behaviors of Tongue Squamous Cell Carcinoma Via Regulating CCR7

Targeted Silencing of Cxcr4 Inhibits Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma

Supplementary Table 1 from CCL26 Participates in the PRL-3–Induced Promotion of Colorectal Cancer Invasion by Stimulating Tumor-Associated Macrophage Infiltration

Supplementary Tables S1-S8 from Targeting the c-Met/FZD8 Signaling Axis Eliminates Patient-Derived Cancer Stem–like Cells in Head and Neck Squamous Carcinomas

MTA3-SOX2 Module Regulates Cancer Stemness and Contributes to Clinical Outcomes of Tongue Carcinoma

Additional File 1 of Association of CASC18/miR-20a-3p/TGFB2 Cerna Axis with Occult Lymph Node Metastasis in Tongue Squamous Cell Carcinoma

Supplemental Tables from Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC

Supplementary Table I and II from PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer

Supplementary Table 1 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression

Supplementary Table S2 from CD36+ Proinflammatory Macrophages Interact with ZCCHC12+ Tumor Cells in Papillary Thyroid Cancer Promoting Tumor Progression and Recurrence

Sox2 Promotes Tumor Aggressiveness and Epithelial‑mesenchymal Transition in Tongue Squamous Cell Carcinoma.

Supplementary Table 1 from A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis